Medical Marijuana Inc (MJNA)

[mchat]

PSID Product Shipped to Korea MJNA Sub Garners International Attention
Posted on August 20, 2014 by admin

Marijuana, Inc. Portfolio Company KannaLife Sciences Covered by International Press for Signing New License With NIH to Develop Treatment for CTE Using Medicinal Marijuana Global News Media Reports on KannaLife Sciences` Government License to Develop Drug to Treat CTE, a Condition Found in Many Retired NFL Players SAN DIEGO, Aug. 20, 2014 (GLOBE NEWSWIRE) – From the US to Turkey, the world is “buzzing” with the news that the National Institutes of Health, a U.S. Government Agency division of the Department of Health and Human Services, has approved KannaLife’s drug discovery plan for using cannabis as the source for a new drug that will treat a concussion syndrome called Chronic Traumatic Encephalopathy or “CTE.” Medical Marijuana, Inc. (OTC Pink: MJNA) is proud to announce that one of its investment portfolio companies, KannaLife Sciences, Inc. (“KannaLife”), is the subject of this tremendous amount of mainstream news coverage. MJNA directly owns 16.70% of KannaLife’s capital stock.
Read more at http://www2.thestockmarketwatch.com/newsletters/2014/08/20/psid-product-shipped-to-korea-mjna-sub-garners-international-attention/#tr5efUIgTLRhg0pc.99


Read more at http://www2.thestockmarketwatch.com/newsletters/2014/08/20/psid-product-shipped-to-korea-mjna-sub-garners-international-attention/#tr5efUIgTLRhg0pc.99